rituximab

Known as: AntiCD20, Ig gamma-1 chain C region, Rituximab CD20 Antibody 
A drug used to treat certain types of B-cell non-Hodgkin lymphoma. It is also used with other drugs to treat chronic lymphocytic leukemia and… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Recent insights in rheumatoid arthritis (RA) necessitated updating the European League Against Rheumatism (EULAR) RA management… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Patients with relapsed chronic lymphocytic leukemia (CLL) who have clinically significant coexisting medical… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2011
Highly Cited
2011
BACKGROUND Patients with follicular lymphoma can have long survival times, but disease progression typically occurs 3-5 years… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND The immunopathogenesis of type 1 diabetes mellitus is associated with T-lymphocyte autoimmunity. However, there is… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND There is increasing evidence that B lymphocytes are involved in the pathogenesis of multiple sclerosis, and they may… (More)
  • figure 1
  • table 1
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
2005
Highly Cited
2005
PURPOSE Fludarabine and cyclophosphamide (FC), which are active in treatment of chronic lymphocytic leukemia (CLL), are… (More)
  • table 1
  • table 2
  • figure 1
  • figure 3
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
The combination of cyclophosphamide, vincristine, and prednisone (CVP) is one of several standard treatment options for advanced… (More)
  • table 1
  • table 2
  • table 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
BACKGROUND An open-label study indicated that selective depletion of B cells with the use of rituximab led to sustained clinical… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
A BSTRACT Background The standard treatment for patients with diffuse large-B-cell lymphoma is cyclophosphamide, doxorubicin… (More)
  • figure 1
  • figure 2
  • table 4
Is this relevant?